Product
Mirtazapine
Aliases
Remeron
Name
Mirtazapine
INN Name
Mirtazapine
FDA Approved
Yes
16 clinical trials
43 organizations
25 indications
3 documents
Indication
Major Depressive DisorderIndication
Functional Disorder of StomachIndication
HealthyIndication
Stimulant Use DisorderIndication
Inflammatory Bowel DiseaseIndication
Methamphetamine Use DisorderIndication
Drug InteractionIndication
Cardiovascular AbnormalitiesIndication
Advanced CancerIndication
AnorexiaIndication
Unintentional Weight LossIndication
InsomniaIndication
Brain GliomaIndication
headacheIndication
Osteoarthritis of the KneeIndication
CancerIndication
MetastasisIndication
Hyperemesis GravidarumIndication
Nausea GravidarumIndication
Nausea and Vomiting of PregnancyIndication
Postoperative Nausea and VomitingIndication
PregnancyIndication
Severe Nausea and VomitingIndication
Bipolar DisorderIndication
Functional DyspepsiaClinical trial
Comparison of Antidepressants in the Real-World: Retrospective Cohort Study Using Big DataStatus: Completed, Estimated PCD: 2022-11-03
Clinical trial
Elucidating Mechanisms That Underlie Symptomatology of Functional Dyspepsia Using Novel Imaging Technique of SPECT/CT, MRI, High-Resolution Manometry and Biomarkers; and the Therapeutic Validation of Elucidated Mechanisms Using Neuromodulator CompoundsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Phase II Randomized, Double-blind, Placebo-controlled Clinical Trial (RCT) to Evaluate the Ability of Mirtazapine (MZP) to Increase Methamphetamine (MA) Abstinence Among Treatment-seeking Medication for Opioid Use Disorder (MOUD) AdultsStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Multi-centre, Double-blind Randomised Controlled Trial to Compare Mirtazapine Versus Placebo Over 12 Weeks in Patients With Multimorbid Major Depression and Inflammatory Bowel Disease (MD-IBD): a Feasibility StudyStatus: Not yet recruiting, Estimated PCD: 2026-02-01
Clinical trial
Phase 1 Safety-interaction Study of Mirtazapine for the Treatment of Methamphetamine Use DisorderStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Preliminary Study to Explore the Effects of Mirtazapine on Appetite in Advanced Cancer PatientsStatus: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
Pilot Study of Mirtazapine for the Dual Treatment of Depression and Temozolomide-Induced Nausea and Vomiting (CINV) in Newly-Diagnosed High-Grade Glioma Patients on Temozolomide TherapyStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache Following Obstetric Surgery Under Spinal Anesthesia: A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-12-20
Clinical trial
Mirtazapine and Quetiapine as Treatment for Postoperative Sleep Disturbance After Fast-track Knee ReplacementStatus: Not yet recruiting, Estimated PCD: 2026-05-01
Clinical trial
Randomized, Double-blind Clinical Trial of the Use of Mirtazapine Versus Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.Status: Completed, Estimated PCD: 2022-02-02
Clinical trial
What is the Effectiveness and Safety of Mirtazapine Versus Escitalopram in Alleviating Cancer-associated Poly-symptomatology (MIR-P)? A Mixed-method Randomized Controlled Trial ProtocolStatus: Terminated, Estimated PCD: 2021-12-17
Clinical trial
Validating the Effect of Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum: A Double-Blind Randomised Placebo-Controlled Multicentre TrialStatus: Terminated, Estimated PCD: 2022-07-31
Clinical trial
Mirtazapine Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting After Lap Cholecystectomy a Comparative StudyStatus: Recruiting, Estimated PCD: 2023-07-28
Clinical trial
Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)Status: Terminated, Estimated PCD: 2023-10-29
Clinical trial
Longitudinal Comparative Effectiveness of Bipolar Disorder TherapiesStatus: Terminated, Estimated PCD: 2019-06-30
Clinical trial
Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight LossStatus: Completed, Estimated PCD: 2011-08-01
Document
DailyMed Label: MirtazapineOrganization
State of Florida DOH Central PharmacyOrganization
Physicians Total Care, Inc.Organization
Rebel Distributors Corp.Document
DailyMed Label: Mirtazapine
Organization
H.J. Harkins Company, Inc.Organization
Preferred Pharmaceuticals Inc.Organization
ATLANTIC BIOLOGICALS CORP.Organization
Aphena Pharma Solutions - Tennessee, LLCOrganization
Sun Pharmaceutical Industries, Inc.Organization
NuCare Pharmaceuticals,Inc.Organization
Quality Care Products LLCOrganization
Advanced Rx Pharmacy of Tennessee, LLCOrganization
Preferred Pharmaceuticals, Inc.Organization
REMEDYREPACK INC. Organization
DIRECT RXOrganization
Proficient Rx LPOrganization
A-S Medication SolutionsOrganization
Direct_RxOrganization
Aurolife Pharma LLCOrganization
Cardinal Health 107, LLCOrganization
Aurobindo Pharma LimitedOrganization
Viona Pharmaceuticals Inc.Organization
bryant ranch prepackOrganization
RPK Pharmaceuticals, Inc.Organization
Apotex Corp.Organization
Lake Erie Medical DBA Quality Care Products LLCOrganization
SQUARE PHARMACEUTICALS LIMITEDOrganization
Mylan Pharmaceuticals Inc.Organization
American Health PackagingOrganization
Prasco LaboratoriesOrganization
Quality Care Products, LLCOrganization
Mylan Institutional Inc.Organization
NCS HealthCare of KY, LLC dba Vangard LabsOrganization
Aphena Pharma Solutions - Tennessee, LLC Organization
AvKAREOrganization
McKesson Corporation dba SKY PackagingDocument
DailyMed Label: REMERONOrganization
Organon LLCOrganization
Rising Pharma Holdings, Inc.Organization
Major PharmaceuticalsOrganization
Golden State Medical Supply, Inc.Organization
Preferred Pharmaceuticals Inc. USAOrganization
Organon LLC Organization
Contract Pharmacy Services-PAOrganization
H.J. Harkins Company, Inc.